4th Quarter - Report
BROWN RUDNICK LLP for APOTEX CORPORATION
Firm
Client
Income
$50,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 2212 & S. 974, the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act; S. 2476-Expanding Access to Low Cost Generic Drugs Act; Issues relating to generic drug pricing; Public Law 115-52 (The FDA Reauthorization Act of 2017)section 808 relating to the Competitive Generic Therapy ("CGT") designation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| HENRY W MENN | CoS, Sen. Bob Graham (01 - 04); Min SD & Counsel, Cmte on Vet Affairs (04); Sp Asst Leg Aff, FDA Off of Commission (93-95) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.